Without transparency, Mr. Merritt, I can't figure out for the life of me why the insurance companies can't deal directly with the manufacturers and the pharmacists and what value is it that you are adding?
Griffith questions the lack of transparency in the relationship between insurance companies and drug manufacturers.
Share
More from Howard Griffith
May I inquire as to the time remaining. The SPEAKER pro tempore (Ms. Foxx). The gentleman from Virginia has 5\1/2\ minutes remaining. The gentleman from New Jersey has 6 minutes remaining.
If WinRed is doing something to make it easier for foreign actors to donate by having massive numbers of small donations sent in, more than happy to look into that; as well as ActBlue.
May I inquire as to how much time is remaining. The SPEAKER pro tempore (Mr. McGuire). The gentleman from Virginia has 2\1/2\ minutes remaining. The gentleman from New Jersey has 8 minutes remaining.
That is correct. The SPEAKER pro tempore. The Chair will not provide an advisory opinion.
Other voices in this conversation
